000 06700cam a2200457M 4500
988 _aSpringer_Medicine_2017
999 _c96496
_d96496
_x1
001 96496
003 ES-MaUEC
005 20230102112756.0
006 m o d
007 cr |n|||||||||
008 170908s2017 xx o 000 0 eng d
020 _a9789811041600
_q(electronic bk.)
020 _a9811041601
_q(electronic bk.)
020 _z9789811041594
020 _z9811041598
040 _aYDX
_beng
_cYDX
_dN$T
_dEBLCP
_dN$T
_dGW5XE
_dOCLCF
_dNJR
_dAZU
_dUPM
_dMERER
_dIOG
_dCOO
_dOCLCO
_dOCLCQ
_dOCLCA
_dES-MaUEC
_bspa
050 4 _aRC280.O8
_b2017 EB
066 _c$1
245 0 0 _aFrontiers in ovarian cancer science
_cHidetaka Katabuchi, editor.
264 1 _a[Lugar de publicación no identificado]
_bSpringer International Publishing
_c2017
300 _a1 recurso en línea
336 _aTexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _atext file
_bPDF
490 0 _aComprehensive gynecology and obstetrics
500 _a
505 0 _aPreface; Contents; 1: Epidemiology and Etiology of Ovarian Cancer; 1.1 Introduction; 1.2 General Epidemiology of Ovarian Cancer; 1.3 Current Status and Changes of Ovarian Cancer Incidence Rate; 1.4 Current Status and Changes of Ovarian Cancer Mortality; 1.5 International Comparison of Ovarian Cancer Incidence Rate and Mortality; 1.6 Risk Factors for Ovarian Cancer; References; 2: Hereditary Ovarian Cancer; 2.1 Introduction; 2.2 Hereditary Breast and Ovarian Cancer (HBOC): BRCA-­Related Breast and Ovarian Cancer; 2.2.1 Clinical and Molecular Features of HBOC
505 8 _a2.2.2 Ovarian Cancer Screening for Surveillance2.2.3 Risk-Reducing Salpingo-Oophorectomy (RRSO); 2.2.4 Chemoprevention; 2.3 Genes Other than BRCA1/2 Involved in Hereditary Ovarian Cancer; 2.3.1 Mismatch Repair Genes (Lynch Syndrome); 2.3.2 Homologous Recombination Deficiency (HRD)-Related Genes; 2.4 PARP Inhibitors; References; 3: Morphological and Molecular Pathogenesis of Epithelial Ovarian Tumors; 3.1 Introduction; 3.2 Representative Theories Related to the Morphological Pathogenesis of EOTs; 3.2.1 The Theory of the Secondary Müllerian System
505 8 _a3.2.2 The Theory of Imported Disease3.3 Two-Tiered Classification for Clinical, Morphological, and Molecular Pathogenesis; 3.4 Morphological and Molecular Pathogenesis in Four Representative Malignant EOTs; 3.4.1 Serous Carcinoma; 3.4.1.1 High-Grade Serous Carcinoma; 3.4.1.2 Low-Grade Serous Carcinoma; 3.4.2 Endometrioid Carcinoma; 3.4.3 Clear Cell Carcinoma; 3.4.4 Mucinous Carcinoma; References; 4: Screening and Prevention of Ovarian Cancer; 4.1 Introduction; 4.2 Materials and Methods; 4.2.1 Search Strategy and Selection Criteria; 4.3 Results
505 8 _a4.3.1 The Systematic Literature Review4.3.2 Ovarian Cancer Screening in the General Population; 4.3.2.1 CA125; 4.3.2.2 Transvaginal Sonography; 4.3.2.3 Two-Stage Strategies; 4.3.3 Ovarian Cancer Screening in the High-Risk Population; 4.4 Prevention of Ovarian Cancer; 4.4.1 Risk-Reducing Surgical Options; 4.4.1.1 Risk-Reducing Salpingo-Oophorectomy (RRSO); 4.4.1.2 Risk-Reducing Oophorectomy (RRO); 4.4.1.3 Risk-Reducing Salpingectomy (RRS); 4.4.1.4 Tubal Ligation; 4.4.2 Risk-Reducing Pharmacologic Options; 4.5 Prevention of Breast Cancer; 4.5.1 Risk-Reducing Surgical Options
505 8 _a4.5.2 Risk-Reducing Pharmacologic Options4.6 Ovarian Cancer Screening in the Japanese Population; 4.7 Discussion; References; 5: Pathology of Epithelial Ovarian Tumors; 5.1 Introduction; 5.2 Classification and Nomenclature of Epithelial Ovarian Tumors; 5.3 Origin of Ovarian Epithelial Tumors; 5.4 Serous Tumors; 5.4.1 Benign Serous Tumors; 5.4.2 Serous Borderline Tumor/Atypical Proliferative Serous Tumor; 5.4.2.1 Usual Serous Borderline Tumor/Atypical Proliferative Serous Tumor; 5.4.2.2 Micropapillary Variant Serous Borderline Tumor (Noninvasive Low-Grade Serous Carcinoma)
520 3 _aThis volume presents the latest advances and the current status of our understanding regarding ovarian cancer, addressing both the basic and clinical aspects of the disease. In terms of basic medicine, the WHO Classification of Tumors of Female Reproductive Organs was revised in 2014, and that version addresses several new concepts and histopathological classifications not previously included. One of the most revolutionary breakthroughs concerns the genesis of epithelial ovarian tumors, shifting the focus from the ovarian surface epithelium to serous tubal intraepithelial carcinomas. Clinically, the mortality rate of epithelial ovarian cancer has gradually increased over the past few decades, making it essential to pursue multidisciplinary treatment and apply novel techniques such as neoadjuvant chemotherapy in daily clinical practice. The primary clinical task is the effective treatment of recurrent ovarian cancer with early palliative medicine. Fertility-sparing surgery may also be pursued depending on histologic subtypes, stage, extent of disease, and preexisting ovarian reserve with the concept of oncofertility. On the basis of the considerations described above, each expert author elucidates the science of ovarian cancer in detail, thus providing a collection that will benefit young medical oncologists and seasoned gynecologists and obstetricians alike.
650 7 _aOvarios
_xCáncer
_2embne
_9225524
700 1 _aKatabuchi, Hidetaka, editor.
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-981-10-4160-0
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
880 0 _6505-00
_a1 Epidemiology and Etiology of Ovarian Cancer -- 2 Hereditary Ovarian Cancer -- 3 Morphologic and Molecular Pathogenesis -- 4 Screening and Prevention of Ovarian Cancer -- 5 Pathology of Epithelial Ovarian Tumors -- 6 Pathology of Non-epithelial Ovarian Tumors -- 7 Ovarian Cancer Genome and Molecular Experimental Sciences -- 8 Strategies for the Management of Epithelial Ovarian Cancer -- 9 Strategies for the Management of Epithelial Ovarian Borderline Tumors -- 10 Strategies for the Management of Non-epithelial 　Ovarian Tumors -- 11 Primary Surgical Treatment of Epithelial Ovarian Cancer -- 12 Primary Chemotherapy and Targeted Molecular Therapy of Epithelial Ovarian Cancer -- 13 Immunotherapy of Epithelial Ovarian Cancer -- 14 Treatment of Recurrent Epithelial Ovarian Cancer -- 15 Management of Adolescent Ovarian Cancer -- 16 Management of Ovarian Cancer in the Elderly Population -- 17 Palliative Medicine in the Management of Ovarian Cancer.
942 _2lcc
_cLE
998 _b02/2018
_dz
_e-
_zSI